Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Actin filament-associated protein 1 (AFAP1) is an adaptor and scaffold protein that interacts with actin filaments and links them to key signaling molecules, notably the SRC family kinases and protein kinase C. AFAP1 modulates cytoskeletal integrity and dynamics in response to cellular signals, promoting the assembly of structures crucial for cell adhesion, migration, and invasion such as podosomes and focal adhesions[1][2][3]. It plays an important regulatory role in cancer cell motility and has been implicated in tumor progression and metastasis[2][3]. Additionally, the AFAP1 gene locus encodes an antisense long non-coding RNA (AFAP1-AS1) that acts as an oncogenic regulator in various tumors[1][4]. AFAP1 is mainly classified as a cytoskeletal adaptor protein rather than a classic enzyme, transporter, or receptor, but its involvement in signal transduction and cancer biology makes it a potential therapeutic target.
No direct small molecule inhibitors reported; the protein acts chiefly as a scaffold/adaptor influencing downstream signaling such as SRC and protein kinase C pathways[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Actin filament-associated protein 1 (AFAP1).